6525--Intent to Sole Source: TheraSphere Y-90 Glass Microspheres

The Department of Veterans Affairs, through the VISN 7 Network Contracting Activity, intends to sole-source a firm-fixed-price contract to Boston Scientific Corporation for the provision of TheraSphere Y-90 Glass Microspheres, a radiopharmaceutical used in selective internal radiation therapy for liver cancer at the Ralph H. Johnson VA Medical Center in Charleston, South Carolina. The base performance period runs from May 1, 2025, through April 30, 2027, with two optional 12-month extension periods at the government’s discretion. This action is justified under FAR 6.302-1, as Boston Scientific is the sole manufacturer of TheraSphere, and no other source can meet the agency’s unique medical requirements. The procurement is not competitive, and no formal proposal evaluation or award determination will be conducted based on responses to this notice. Contractors are invited to submit capability statements by February 20, 2026, at 10:00 AM ET via email to the Contracting Officer, LaTerrica Sewell, but these submissions will not trigger a competitive process or influence award decisions. The product must comply with pharmaceutical manufacturing standards under NAICS code 325412, with an employee-based size standard of 1,300, and packaging, labeling, and preservation must ensure sterility, radioactive containment, and traceability in accordance with federal and industry norms for radiopharmaceuticals. Delivery and acceptance will occur at the Charleston, SC medical center, although specific packaging, shipping, invoicing, and accounting details are not provided. The contracting office is located in Augusta, GA, and while the Contracting Officer is identified, no Contracting Officer’s Representative or technical point of contact is named. No contract value is disclosed, and no MIL-STD, specific labeling formats, or formal contract clauses are detailed beyond the sole-source justification.